Format

Send to

Choose Destination
Expert Rev Proteomics. 2016;13(4):421-33. doi: 10.1586/14789450.2016.1164604.

The current state of the art of quantitative phosphoproteomics and its applications to diabetes research.

Author information

1
a Biological Sciences Division and Environmental Molecular Sciences Laboratory , Pacific Northwest National Laboratory , Richland , WA , USA.

Abstract

Protein phosphorylation is a fundamental regulatory mechanism in many cellular processes and aberrant perturbation of phosphorylation has been implicated in various human diseases. Kinases and their cognate inhibitors have been considered as hotspots for drug development. Therefore, the emerging tools, which enable a system-wide quantitative profiling of phosphoproteome, would offer a powerful impetus in unveiling novel signaling pathways, drug targets and/or biomarkers for diseases of interest. This review highlights recent advances in phosphoproteomics, the current state of the art of the technologies and the challenges and future perspectives of this research area. Finally, some exemplary applications of phosphoproteomics in diabetes research are underscored.

KEYWORDS:

LC-MS/MS; Phosphoproteomics; diabetes; phosphopeptide enrichment; phosphorylation; quantification; targeted proteomics

PMID:
26960075
PMCID:
PMC4939282
DOI:
10.1586/14789450.2016.1164604
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center